Escherichia coliStrains of Serotype O51:H40 Comprise Typical and Atypical Enteropathogenic E. coliStrains and Are Potentially Diarrheagenic

Autor: Moreira, Fabiana C., Vieira, Mo^nica A. M., Ferreira, Antonio J. P., o, Vaz, Ta^nia M. I., Rosa, Ana Cla´udia P., Knobl, Terezinha, Irino, Kinue, Freymu¨ller, Edna, Gomes, Ta^nia A. T.

Publikováno v: Journal of Clinical Microbiology; April 2008, Vol. 46 Issue: 4 p1462-1465, 4p

Metal complexes of 1-oxa-4,7,10-triazacyclododecane-N,N′,N″-triacetic acid

Autor: Cândida M, Amorim Mt, Vaz Ta, da Silva Jj, M.F.C. Vilhena, Rita Delgado

Publikováno v: Talanta. 35:741-745

The macrocyclic complexone 1-oxa-4,7,10-triazacyclododecane- N , N′ , N″ -triacetic acid (cODTA) has been synthesized and its protona constants, stability constants of metal complexes and enthalpy changes for the formation of alkaline-earth compl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2114102c377573a7661a28f69662adf8
https://doi.org/10.1016/0039-9140(88)80175-9

Biotyping, serotyping and ribotyping as epidemiological tools in the evaluation of Acinetobacter baumannii dissemination in hospital units, Sorocaba, São Paulo, Brazil

Autor: GONÇALVES Célia R., VAZ Tania Mara I., ARAUJO Eliane, BONI Regina de Fátima, LEITE Daniela, IRINO Kinue

Publikováno v: Revista do Instituto de Medicina Tropical de São Paulo, Vol 42, Iss 5, Pp 277-282 (2000)

Dissemination of Acinetobacter baumannii strains in different units of a hospital in Sorocaba, São Paulo, Brazil was evaluated over a period of two years. By using biotyping, serotyping and ribotyping, 27 distinct clones were differentiated among 76

Externí odkaz: https://doaj.org/article/341a0e569a0a4ebc95fed63008279001

Inability to Decarboxylate Lysine as a Presumptive Marker To Identify Shiga Toxin-Producing Escherichia coliStrains of Serogroup O111

Autor: Guth, Beatriz E. C., Gomes, TA^nia A. T., Vaz, TA^nia M. I., Irino, Kinue

Publikováno v: Journal of Clinical Microbiology; July 2003, Vol. 41 Issue: 7 p3450-3450, 1p

COVID-19 and pregnancy: A European study on pre- and post-infection medication use.

Autor: Hurley E; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., Geisler BP; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway.; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Lupattelli A; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., Poblador-Plou B; EpiChron Research Group, Aragon Health Sciences Institute, Miguel Servet University Hospital, Saragossa, Spain.; Network for Research on Chronicity, Primary Care, and Health Promotion, Research Network on Health Services in Chronic Diseases, Institute of Health Carlos III, Madrid, Spain., Lassalle R; Bordeaux PharmacoEpi, Plateforme de recherche en Pharmaco-épidémiologie, Bordeaux, France., Jové J; Bordeaux PharmacoEpi, Plateforme de recherche en Pharmaco-épidémiologie, Bordeaux, France., Bernard MA; Bordeaux PharmacoEpi, Plateforme de recherche en Pharmaco-épidémiologie, Bordeaux, France., Sakr D; Bordeaux PharmacoEpi, Plateforme de recherche en Pharmaco-épidémiologie, Bordeaux, France., Sanfélix-Gimeno G; Health Services Research and Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain., Sánchez-Saez F; Health Services Research and Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain., Rodríguez-Bernal CL; Health Services Research and Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain., Sabaté M; Department of Clinical Pharmacology, Vall d`Hebron Hospital Universitari, Vall Hebron Institut de Recerca, Barcelona, Spain., Ballarín E; Department of Clinical Pharmacology, Vall d`Hebron Hospital Universitari, Vall Hebron Institut de Recerca, Barcelona, Spain., Aguilera C; Department of Clinical Pharmacology, Vall d`Hebron Hospital Universitari, Vall Hebron Institut de Recerca, Barcelona, Spain., Jordan S; Faculty of Medicine, Health and Life Science, Swansea University, Swansea, Wales, UK., Thayer D; Faculty of Medicine, Health and Life Science, Swansea University, Swansea, Wales, UK., Farr I; Faculty of Medicine, Health and Life Science, Swansea University, Swansea, Wales, UK., Ahmed S; Faculty of Medicine, Health and Life Science, Swansea University, Swansea, Wales, UK., Bartolini C; Agenzia Regionale di Sanità della Toscana, Florence, Italy., Limoncella G; Agenzia Regionale di Sanità della Toscana, Florence, Italy., Paoletti O; Agenzia Regionale di Sanità della Toscana, Florence, Italy., Gini R; Agenzia Regionale di Sanità della Toscana, Florence, Italy., Maglanoc LA; IT Department, Data Management, University of Oslo, Oslo, Norway., Dudukina E; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Ehrenstein V; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Alsina E; Department of Data Science and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Vaz TA; Department of Data Science and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Riera-Arnau J; Department of Clinical Pharmacology, Vall d`Hebron Hospital Universitari, Vall Hebron Institut de Recerca, Barcelona, Spain.; Department of Data Science and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Sturkenboom MCJM; Department of Data Science and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Nordeng HME; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway. h.m.e.nordeng@farmasi.uio.no.; Department of Child Health and Development, Norwegian Institute of Public Health, Oslo, Norway. h.m.e.nordeng@farmasi.uio.no.

Publikováno v: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2024 May; Vol. 80 (5), pp. 707-716. Date of Electronic Publication: 2024 Feb 12.